logo

Allena Pharmaceuticals, Inc. (ALNA)



Trade ALNA now with
  Date
  Headline
6/20/2018 7:13:54 AM Wedbush Reiterates Allena Pharmaceuticals, Inc. (ALNA) At Outperform With $38 Price Target
6/19/2018 8:22:59 AM Allena Completes Animal Proof-of-Concept Study For ALLN-346
6/11/2018 8:07:09 AM Allena Pharmaceuticals Appoints Andrew Hack To Board Of Directors
5/8/2018 8:11:08 AM Allena Q1 Net Loss $7.9 Mln Or $0.38/Shr
3/28/2018 8:46:00 AM Wedbush Is Lowering Allena Pharmaceuticals, Inc. (ALNA) FY18 Estimate To -1.50 From -1.48
3/28/2018 8:45:46 AM Wedbush Is Cutting Allena Pharmaceuticals, Inc. (ALNA) Q2 18 Estimate To -0.38 From -0.37
3/28/2018 8:45:36 AM Wedbush Is Cutting Allena Pharmaceuticals, Inc. (ALNA) Q1 18 Estimate To -0.38 From -0.37
3/28/2018 8:45:02 AM Wedbush Reiterates Allena Pharmaceuticals, Inc. (ALNA) At Outperform With $37 Price Target
3/27/2018 8:10:24 AM Allena Pharma Q4 Net Loss $6.68 Mln Or $0.48/Shr Vs Loss $6.22 Mln Or $4.65/Shr Last Year
3/6/2018 8:11:57 AM Allena Begins First Phase 3 Trial For ALLN-177 In Patients With Enteric Hyperoxaluria
12/18/2017 6:21:31 AM Wedbush Is Lowering Allena Pharmaceuticals, Inc. (ALNA) 2018 Estimate To -1.48 From -1.42
12/18/2017 6:21:12 AM Wedbush Is Lowering Allena Pharmaceuticals, Inc. (ALNA) Q4 18 Estimate To -0.37 From -0.35
12/18/2017 6:21:01 AM Wedbush Is Cutting Allena Pharmaceuticals, Inc. (ALNA) Q3 18 Estimate To -0.37 From -0.35
12/18/2017 6:20:50 AM Wedbush Is Cutting Allena Pharmaceuticals, Inc. (ALNA) Q2 18 Estimate To -0.37 From -0.35
12/18/2017 6:20:23 AM Wedbush Is Lowering Allena Pharmaceuticals, Inc. (ALNA) Q1 18 Estimate To -0.37 From -0.36
12/18/2017 6:20:04 AM Wedbush Is Raising Allena Pharmaceuticals, Inc. (ALNA) 2017 Estimate To -0.55 From -0.58